Supercharge new treatment development.

We map the complete landscape of KOLs, DOLs, and PAGs across every therapeutic area, then accelerate clinical trial enrollment through targeted digital recruitment.

Book a demo

Explore example profiles. Hover or tap a dot on the helix.

Selected clients of Adnexi

  • Johnson & Johnson
  • Amgen
  • Daiichi Sankyo
  • Biogen
  • Otsuka
  • UCB
  • Boston Scientific
  • Tanabe Pharma
  • Syneos Health
  • Avidity Biosciences

Built around your disease

We agree the indication, patient population and countries with your team before we begin. That scope guides the search for experts and the criteria used to rank them.

Agreed disease terms
Your team approves the search terms, including disease names, subtypes and abbreviations. These terms determine which publications count toward a ranking.
Research and clinical experience
Review publications, trial roles and congress presentations together in each expert profile.
Updated daily
Profiles are updated daily as new source records become available.
An illustration of a disease-specific search, grouping relevant experts, digital opinion leaders, advocacy groups and trial sites.

Expert engagement and trial recruitment

Build an advisory board, research potential trial sites, or plan outreach to patient groups. For recruitment campaigns, track referrals and site follow-up through enrollment.

KOL and DOL intelligence

Review a key opinion leader's publications, trial experience and industry payments. Follow what digital opinion leaders post about your disease or treatment. Rankings use criteria agreed with your team.

  • Disease-specific rankings with supporting records
  • Social posts, audience size and recent activity
  • Export profiles and lists for your team

Ranking weights

Try example weights
  1. 1Dr. Kathleen RuskILD program director, Boston96882286
  2. 2Dr. Victor SalcedoTrial investigator, Houston71953074
  3. 3Dr. Janet LeungThoracic radiologist, San Francisco90382668
  4. 4Dr. Douglas PennerPulmonologist, Denver58796165
  5. 5Dr. Denise FeldmanPulmonologist and educator, Chicago62549363
  6. 6Curtis Talbot, RRTRespiratory therapist, Phoenix1069818

Dr. Kathleen Rusk ranks first at these weights. Strongest score: research, 96 of 100.

Patient advocacy intelligence

See which patient organizations and online communities are active in your disease, and how well each one fits your program. Every group is researched and scored, and its profile shows the evidence behind each score.

  • Scored on trial work, sponsors, policy and diversity
  • Leadership contacts, chapters, events and recent posts
  • Your team's notes and outreach log on every profile

Trial collaboration

Example data

  • Breathe ForwardPatient organization, 48K followers High

    Runs a pulmonary fibrosis trial finder and has co-hosted two webinars with sponsors.

    6 sponsors9 engagements
    Joanna ReyesChief Executive
    Patient summitNov 14, Chicago
  • Open Air AlliancePatient community, 31 chapters, 22K followers High
  • Fibrosis FamiliesCaregiver group, 15K followers Medium
  • Lung Rehab VoicesFacebook group, 9.8K members Low

Influence mapping

We survey healthcare professionals about the colleagues they consult and refer patients to. Comparing those nominations with research and digital activity helps your team choose whom to involve in an advisory board or launch program.

  • Peer nominations by country and region
  • Referral relationships between healthcare providers
  • Peer recognition alongside scientific and digital activity
  • Findings for advisory boards and launch planning
Scientific leadership Patient-facing influence Both Kathleen Rusk Victor Salcedo Denise Feldman Janet Leung Douglas Penner

Patient recruitment

We run digital campaigns that help people learn about a study and complete a prescreener. People who pass can be referred, with their consent, to a participating site. Site teams assess eligibility and record screening and enrollment outcomes in the portal.

  • Study pages and prescreeners in local languages
  • Checks for bots, duplicate submissions and suspected fraud
  • Referrals to participating sites in the study
  • A site portal for contact attempts and screening outcomes
Example studyEN

Has a doctor told you that you have pulmonary fibrosis?

Demo only. Answers are not sent or saved.

IPF-204, phase 2b Example data, last 90 days
Prescreens
1,240
Likely eligible
412
Referred to sites
238
Screened
96
Randomized
41
Median days to site contact1.8
Referral to screening40%
Sites accepting38 of 41
Example site matches
  • Site 108, Houston, TX12 mi, accepting
  • Site 112, Sugar Land, TX19 mi, accepting
  • Site 131, Galveston, TX31 mi, waitlist

Ask Adnexi

Ask about experts, patient groups or clinical trials using the information in your team's Adnexi workspace.

Ask Adnexi IPF example

Which Texas experts have IPF trial experience?

In this example, Dr. Victor Salcedo in Houston is listed as an investigator on two phase 3 IPF trials. His profile includes the trial records so you can check his role and the study dates.

Case studies

All case studies
  1. 22 patients randomized in 12 months, about 30% of trial enrollmentPhase 3, ultra-rare disease
    Prescreened
    82
    Screened
    46
    Randomized
    22
  2. 14 participants enrolled through advocacy outreach, 18% of trial enrollmentRare oncology
    17 patient advocacy DOLs engaged144 discussion guides downloaded95 prescreeners in 7 months
  3. 24 patients randomized in 9 months in a program supporting 50 US and Canadian sitesPhase 2, neurodegenerative disease
    Prescreened
    250
    Screened
    52
    Randomized
    24
  4. 77 digital opinion leaders profiled and tracked for a digital therapeutic launchDigital therapeutic
    160 clinicians surveyed on credibility10+ leaders engaged in the launch
  5. 40 digital opinion leaders posting about osteoporosis identified for a planned brand launchOsteoporosis
    Filtered by geography, language, recency and channelTracked through their social feeds

Compliance and data protection

IRB and ethics review
Study pages, ads and prescreeners are prepared for IRB or ethics committee review before use.
Patient data access
Patient identities are hidden by default in sponsor dashboards. Access to identifying information is restricted by the user's role and study permissions.
Regional data storage
Prescreener records for UK, German, French, Italian and Dutch studies are stored in Frankfurt. Our privacy policy explains data access and international transfers.
Data Privacy Framework certified
Adnexi is certified under the EU-U.S. Data Privacy Framework, its UK Extension and the Swiss-U.S. Data Privacy Framework.
Bot and duplicate screening
We check submissions for bot activity, duplicate entries and suspicious answer patterns before referral.
Per-user access
Users see the diseases and studies they have permission to access. Microsoft single sign-on is available.